|
Steve has played a central role in establishing drug discovery and development partnerships for Neurogen valued at over $400 million and has also guided the Company in raising more than $175 million in equity financings. He came to Neurogen in 1994 after having practiced as a corporate and securities attorney with a Wall Street law firm and as a Certified Public Accountant with a global public accounting firm. Steve is responsible for the business operations of Neurogen including the business development, finance, and legal functions of the Company. Prior to joining Neurogen as Chief Financial Officer, he practiced as a corporate and securities attorney with Milbank, Tweed, Hadley and McCloy in Manhattan. At Milbank, Steve focused on transactions which raised capital in public and private markets for established companies, as well as the formation of numerous joint ventures and alliances. He began his career with Arthur Andersen & Co. in Oklahoma, where he focused on auditing and advising clients in regulated industries. Steve holds a B.S. in accounting from Southern Nazarene University in Oklahoma and the J.D. from Vanderbilt University in Tennessee.
| 